Form 4: Strata Medical Co-CEO Acquires Shares, Covers Taxes

Strata Critical Medical's Co-CEO and CFO, William A. Heyburn, acquired 181,072 shares through PSU vesting and subsequently disposed of 100,133 shares for tax obligations.

Summary

• William A. Heyburn, Co-CEO and CFO of Strata Critical Medical, Inc., acquired 181,072 shares of Class A common stock on October 31, 2025.
• These shares were acquired due to the vesting of performance-based restricted stock units (PSUs) granted on March 8, 2024, after the Compensation Committee certified that performance criteria were met.
• On November 3, 2025, Heyburn disposed of 100,133 shares of Class A common stock at a price of $5.03 per share.
• This disposition was executed to satisfy tax withholding obligations related to the PSU vesting.
• Following these transactions, Heyburn directly beneficially owns 1,386,436 shares of Class A common stock.

Sentiment

Score: 7

Explanation: The vesting of performance-based restricted stock units indicates the achievement of company or individual performance targets, which is a positive signal. The subsequent sale of shares for tax purposes is a routine and expected event, not significantly impacting sentiment.

Positives

• The Compensation Committee certified the satisfaction of performance criteria for performance-based restricted stock units (PSUs) granted to William A. Heyburn, leading to the vesting of 181,072 shares.
• The vesting of PSUs indicates that the company or Heyburn met specific performance targets, which can be viewed as a positive operational signal.

Negatives

• 100,133 shares were disposed of to cover tax withholding obligations, resulting in a reduction of direct beneficial ownership.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The vesting of performance-based restricted stock units suggests that management has met specific performance targets, which could be viewed as a positive indicator of company performance.
• Employees: This transaction reflects standard executive compensation practices involving performance-based equity, which is common across many publicly traded companies.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where the Co-CEO and CFO acquired shares through the vesting of performance-based restricted stock units (PSUs) and subsequently sold a portion to cover tax obligations. While the PSU vesting indicates the achievement of performance criteria, which is a positive operational sign, the overall transaction is a standard compensation event and does not provide new fundamental information that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing does not present new catalysts for significant price movement.

Keywords

Strata Critical Medical, SRTA, Form 4, insider transaction, stock acquisition, PSU vesting, executive compensation, William A. Heyburn